GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia
Clinical trial NCT01518517 · COMPLETED
Trial details
- NCT number
- NCT01518517
- Sponsor
- ERYtech Pharma
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-09-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.